Zum Inhalt

Therapeutic Keratopigmentation: Cosmetic and Functional Outcomes

  • Open Access
  • 03.04.2025
  • ORIGINAL RESEARCH
Erschienen in:

Abstract

Introduction

This work aimed to assess the safety and outcomes of femtosecond laser-assisted intrastromal keratopigmentation (FIK) and superficial automated keratopigmentation (SAK) using micronized mineral pigments (MMPs) as a therapeutic cosmetic tool.

Methods

Keratopigmentation (KTP) was performed in 85 eyes of 85 patients with moderate-to-severe cosmetic disabilities (20/80 to no light perception) related to various etiologies causing corneal scarring or iris abnormalities. Thirty-six eyes were treated by FIK, 46 eyes by SAK, and three eyes using combined SAK + FIK. The cosmetic outcome, patient satisfaction, and occurrence of any related complications were recorded. The cosmetic or visual outcome was assessed through patient-reported feedback, while an independent observer evaluated the cosmetic appearance at the 6th month postoperatively. The mean follow-up period was 13.06 ± 9.9 months (6–53 months).

Results

The study included 48 males and 37 females. The mean age was 37.8 ± 14.25 (14–77 years). An independent observer assessed the cosmetic outcome as excellent or good in 91.8% of cases. Excellent or good cosmetic outcome was reported by the independent observer in 91.4% of the SAK group, 91.5% of the FIK group, and 100% of SAK + FIK combined. Eighty percent of patients reported cosmetic satisfaction 3 weeks postoperative; 73.9% of SAK group, 86% of FIK group, and 100% of the combined SAK + FIK group were satisfied with their cosmetic outcome. Twelve eyes of SAK and five eyes of FIK group required additional KTP procedures because of color fading and cosmetic unsatisfaction. Post-operative symptoms were photophobia (28.2%), tearing (23.5%), and pain (8.2%). Post-operative complications were dry eye (5.8%), delayed epithelial healing (2.3%), and microbial keratitis (1.1%).

Conclusions

This study confirms that FIK and SAK using micronized mineral pigments are safe and efficient surgical techniques for managing cosmetic and visual disabilities caused by iris abnormalities and cosmetic issues related to corneal scars.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s40123-025-01131-0.
Key Summary Points
Keratopigmentation (KTP) is an ophthalmic procedure that has been utilized for both therapeutic and cosmetic goals.
This study is designed to assess the safety and outcomes of femtosecond laser-assisted intrastromal keratopigmentation (FIK) and superficial automated keratopigmentation (SAK) using micronized mineral pigments (MMPs).
Eighty percent of patients reported cosmetic satisfaction 3 weeks post-op.
An independent observer assessed the cosmetic outcome as excellent or good in 91.8% of cases, 6 months post-op.
Post-operative symptoms were photophobia, tearing, and pain.
Post-operative complications were dry eye, delayed epithelial healing, and microbial keratitis.
This study confirms that SAK and FIK using micronized mineral pigments are safe and efficient therapeutic surgical techniques for the management of cosmetic and functional disabilities caused by corneal opacities of a variety of etiologies and iris abnormalities.

Introduction

Keratopigmentation (KTP), commonly called corneal tattooing, is an ophthalmic procedure that has the potential to be utilized for both therapeutic and cosmetic goals. Both the cosmetic and therapeutic (functional) aspects of KTP are beneficial to eyes that have been altered in appearance due to corneal opacifications (leukomas) and iris abnormalities caused by various pathologies. Using this technique, pigments are applied to the cornea to alter its cosmetic appearance or treat vision problems caused by iris abnormalities. The efficacy and safety of KTP have been enhanced by the development of micronized mineral pigments and advancements in surgical methods, particularly the use of modern technologies like femtosecond lasers [14, 8, 11, 15]. KTP has shown encouraging results in treating patients with moderate-to-severe visual impairments by reducing light scattering and photophobia in subjects with aniridia or iris coloboma and in patients with symptomatic glare related to iris loss, atrophy, or trauma [2, 57, 12, 13]. Moreover, KTP has even been applied for pure cosmetic purposes, allowing healthy individuals to voluntary change the visible color of their eyes [9].
This procedure has previously been reported to achieve high patient satisfaction in terms of both cosmetic and symptomatic relief, along with successful cosmetic and functional outcomes and minimal complications [811, 14, 15]. KTP frequently eliminates the need for anterior chamber invading (intraocular) procedures in order to improve the cosmetic appearance of the eye, such as iris implants, iris reconstructive surgeries, and keratoplasty, bypassing their potential serious complications like endophthalmitis, increased intraocular pressure (IOP), and uveitis [11]. Historically, KTP has been used for managing disfiguring corneal opacities, and a thorough review of the procedure demonstrates its expanded clinical applications because of low complication rates and advancements in surgical techniques [12, 13].
KTP techniques have advanced significantly by innovation of automated pigment-delivering devices and evolution of femtosecond laser technology for creating intrastromal pockets, providing a range of methods for both cosmetic and functional purposes. These techniques are divided into two categories: superficial and intrastromal. Superficial manual keratopigmentation (SMK) and superficial automated keratopigmentation (SAK) are categories within the superficial KTP. Manual intrastromal keratopigmentation (MIK) and femtosecond laser-assisted intrastromal keratopigmentation (FIK or FAK) are the two subtypes of the intrastromal technique [14, 15]. Each technique has its own advantages and indications, but their overall goals are to improve the eye’s cosmetic appearance or treat functional impairments brought on by iris defects and corneal conditions. Technique selection usually takes into account the needs of each patient, the degree of corneal involvement, and the intended cosmetic result.
The aim of this study is to assess the safety and cosmetic and functional outcomes of KTP (SAK and FIK) using micronized mineral pigments (MMP) in patients with moderate-to-severe cosmetic or visual impairment who have visual symptoms, cosmetic complaints, or both.

Methods

Study Design

This study is a retrospective consecutive study. Prior to surgery, standardized informed consent was obtained, and the cosmetic goals and potential complications were explained to participants both verbally and through a written information sheet. This study adhered to the principles of the Declaration of Helsinki. Ethical approval for this retrospective investigation was obtained from the Ethics Committee of Iran University Faculty of Medicine. Written consent was obtained from participants for the publication of their preoperative and postoperative photos.

Patients

Patients with moderate-to-severe visual impairment who had visual complaints, cosmetic concerns, or both due to iris abnormalities and/or corneal scars and were referred to the Iranian Eye Clinic (Tehran, Iran) from 2018 to 2023 were included in this study. All patients underwent thorough ophthalmic examinations, including best-corrected visual acuity, slit-lamp biomicroscopy, and indirect ophthalmoscopy. Anterior segment optical coherence tomography (OCT) and corneal topography using MS-39 (SCHWIND eye-tech-solutions GmbH, Germany) were performed for all patients. Based on the depth of corneal scar/opacity acquired by OCT and cause of visual/cosmetic impairment, patients were assigned to undergo superficial, intrastromal, or a combined superficial + intrastromal KTP. Patients with clear cornea and iris abnormalities were candidate for performing FIK. When the corneal opacity and scar was diffuse or dense, intrastromal staining was insufficient to provide a satisfactory cosmetic appearance or estimated that femtosecond laser was unapplicable; hence, superficial KTP was performed. Patients with relatively clear cornea were scheduled for combined technique. The depth of tunnel creation was determined by MS-39. All surgeries were performed by a single experienced surgeon (SJH). The minimum follow-up requested for the inclusion of this investigation was 6 months.

Surgical Techniques

Micronized Mineral Pigments (MMPs)

MMPs' embedded nature diminishes the inflammatory response in the cornea, while their small particle size (≤ 2.5 µm) lessens foreign-body reactions [16]. Gamma-irradiated micronized mineral pigments in four different colors were used. Blue, green, brown, and black were the colors that were used to simulate the iris's natural color (CE mark 0499; BIOTIC PHOCEA, France).

Femtosecond Laser-Assisted Intrastromal Keratopigmentation (FIK)

Using a femtosecond laser LDV Z6 (Ziemer Ophthalmic Systems, Port, Switzerland) under topical anesthesia with tetracaine 0.5% eye drop, a circular tunnel with external and internal diameters of 9.5 and 4.0 mm and one superior 90° radial incision of 3 mm and one inferior incision was created. These incisions were made at half the depth of the thinnest cornea. A 27-gauge cannula was used to inject the pigments through the incisions after the tunnel was opened.

Superficial Automated Keratopigmentation (SAK)

Generally, superficial KTP can be used when intrastromal KTP is insufficient to provide an acceptable appearance [11, 12]. The Biocea® Innov' dermograph (BIOTIC PHOCEA, France) was used to perform SAK. The device makes use of rotary micromotors that have been specifically engineered and tuned for use in various dermopigmentation procedures. Under topical and retrobulbar anesthesia, after epithelial removal, a drop of color was instilled on the corneal surface and automatic micropunctures were used to penetrate anterior stroma to a depth of about 120 μm below the corneal surface. A trundle in the handpiece's distal section controlled the needles' penetration depth. Depending on the area to be treated, different tips and different numbers of needles were used. The depth of implantation of MMP in cornea was adjusted with handpiece micrometer controller. The handpiece has two different tips: the first with a single needle for fine KTP application and the second with three needles for broader KTP coverage.

Outcome Measures

Six months following the procedure, an independent observer assessed the cosmetic result based on pigment stability, level of color similarity to the healthy eye, and created pupil shape and size. This assessment was divided into three categories: excellent (excellent symmetry with the fellow eye and excellent cosmetic appearance), good (symmetrical and acceptable cosmetic appearance), or poor (asymmetrical and unacceptable cosmetic appearance). The patient's reported outcome (level of cosmetic and functional satisfaction) was evaluated and classified as highly satisfied, satisfied, or unsatisfied, according to oral interview and/or written questionnaire, 3 weeks after the procedure (the questionnaire is available as Supplementary Material). During the follow-up period, the stability of pigmentation and the existence of any associated complications were also assessed.

Post-operative Management

At the end of the procedure, a bandage contact lens was placed for all cases and continued for 3 weeks or up to completion of corneal epithelial healing. Topical antibiotic drop (levofloxacin 0.5%) was administered four times daily up to bandage contact lens removal. Topical steroid drop (betamethasone 0.1%) was administered four times daily and tapered during 1 month. Topical autologous serum 20% drop four times daily besides frequent topical artificial tears drop was also prescribed. Follow-up visits were 1 day post-operative, 3 weeks post-operative, and every 3 months for an unlimited period based on patient satisfaction or any complaints.

Results

A total of 85 eyes from 85 patients, including 48 males and 37 females, were reviewed. The mean age was 37.8 ± 14.25 years (range, 14–77 years). Visual acuity status of the eyes and causes of visual or cosmetic complaints are shown in Tables 1 and 2. All patients were unsatisfied with their eye appearance. Twenty-one patients experienced visual symptoms, including photophobia, glare, halos, and monocular diplopia, in addition to cosmetic concerns due to iris abnormalities. Patients were assigned to receive either superficial automated keratopigmentation (SAK) or femtosecond laser-assisted intrastromal keratopigmentation (FIK) based on pre-operative evaluations. Forty-six eyes underwent SAK, while 36 eyes received FIK. Three eyes underwent a combined SAK + FIK procedure. Additionally, 13 eyes required superficial keratectomy with 2% EDTA to remove calcified band keratopathy. The mean follow-up period was 13.06 ± 9.9 months (range, 6–53 months).
Table 1
Visual status of participants
Visual acuity
Number of cases
NLP
53
LP
18
HM
5
HM to 20/400
4
20/400 to 20/200
3
20/200 to 20/80
2
NLP no light perception, LP light perception, HM hand motion
Table 2
Causes of cosmetic or visual complaints
Main causes of cosmetic/visual complaints
Number of cases
Traumatic corneal scar and iris defect
53
Corneal scarring due to vitreoretinal surgery
14
Corneal scarring due to old keratitis/uveitis
5
Failed penetrating keratoplasty
4
Heterochromia
3
Congenital leukoma
2
Depigmented iris due to laser
1
Congenital glaucoma
1
Limbal dermoid scarring
1
Corneal decompensation
1

Cosmetic Outcome

Cosmetic outcomes evaluated by an independent observer 6 months postoperative are shown in Table 3. In general, the independent observer assessed the cosmetic outcome excellent or good in 91.8% of cases (78 out of 85 patients). Excellent or good cosmetic outcome was reported by the independent observer in 91.4% of SAK group (42 out of 46 patients), 91.5% of FIK group (33 out of 36 patients), and 100% of combined SAK + FIK (three patients). In total, the cosmetic outcome was evaluated as poor in 8.2% (seven out of 85 patients). The cosmetic outcome was reported to be poor in 8.6% (four out of 46 patients) of SAK group and 8.5% (three out of 36 patients) of FIK group, 6 months postoperative.
Table 3
Independent observer’s evaluation results
Cosmetic outcome
Number of cases
%
Total
85
 
 Excellent
45
53
 Good
33
38.8
 Poor
7
8.2
SAK
46
 
 Excellent
24
52.2
 Good
18
39.2
 Poor
4
8.6
FIK
36
 
 Excellent
19
52.7
 Good
14
38.8
 Poor
3
8.5
SAK + FIK
3
 
 Excellent
2
66.7
 Good
1
33.3
 Poor
0
0
SAK superficial automated keratopigmentation, FIK femtosecond laser-assisted intrastromal keratopigmentation

Patient-Reported Outcomes

Table 4 represents patient-reported cosmetic outcomes. In total, 68 of 85 patients (80%) reported cosmetic satisfaction (40% highly satisfied and 40% satisfied) 3 weeks postoperative; 73.9% of SAK group (34 out of 46 patients), 86% of FIK group (31 out of 36 patients) and 100% of combined SAK + FIK group (three patients) were highly satisfied or satisfied with their cosmetic outcome. In general, 20% (17 out of 85 patients) were unsatisfied with the outcome in week 3 postoperative; 26.1% (12 out of 46 patients) of the SAK group and 14% (five out of 36 patients) were unsatisfied with their cosmetic outcome 3 weeks postoperative.
Table 4
Patient-reported cosmetic outcome
Patient satisfaction
Number of cases
%
Total
85
 
 Highly satisfied
34
40
 Satisfied
34
40
 Unsatisfied
17
20
SAK
46
 
 Highly satisfied
19
41.3
 Satisfied
15
32.6
 Unsatisfied
12
26.1
FIK
36
 
 Highly satisfied
12
33.3
 Satisfied
19
52.7
 Unsatisfied
5
14
SAK + FIK
3
 
 Highly satisfied
3
100
 Satisfied
0
0
 Unsatisfied
0
0
SAK superficial automated keratopigmentation, FIK femtosecond laser-assisted intrastromal keratopigmentation

Functional Outcome

All 21 patients with visual symptoms reported significant improvement. Among them, 16 eyes underwent FIK, three eyes received SAK, and two eyes underwent a combined SAK + FIK procedure. No patient reported functional dissatisfaction. Overall, 18 patients (75%) were highly satisfied, while three patients (25%) were satisfied with their functional outcome.

Pigment Stability

During the follow-up period, 17 cases (20%) of pigment fading were observed. One case of pigment migration approximately 5 years after FIK was observed. A repeat of the initial procedure was required for 12 eyes in the SAK group and five eyes in the FIK group. The average duration of fading after the initial procedure was 3.35 ± 2.9 months.

Post-operative Symptoms and Complications

Symptoms

Photophobia, tearing, and pain occurred in 24 (28.2%), 20 (23.5%), and seven (8.2%) eyes, respectively. Twenty eyes with photophobia (83.3%), 18 eyes with tearing (90%), and six eyes with pain (85.7%) were in the SAK group. Mentioned symptoms were managed by topical steroid (betamethasone 0.1%), cycloplegic (atropine 1%), and artificial tears. Symptoms revealed within 4–6 weeks in all cases.

Complications

In total, eight eyes (9.4%) developed complications. No intra-operative complication occurred. Five eyes (5.8%), all in the SAK group presented with dry eye as filamentary keratitis. Filamentary keratitis was managed by filament removal, frequent lubrication, topical acetylcysteine 10%, and bandage contact lens. Persistent epithelial defect occurred in two eyes (2.3%), which were in the SAK group. The first case was managed by frequent lubrication, extending bandage contact lens use, and lateral tarsorrhaphy. The second case was managed by frequent lubrication, lateral tarsorrhaphy, and amniotic membrane transplantation. This eye further developed fungal keratitis, which was managed by penetrating keratoplasty. One eye (1.1%) in the SAK group developed microbial keratitis, which was bacterial (Gram-positive cocci) in nature. Keratitis was managed by topical fortified antibiotic eye drops until resolution of the infection with scar formation.

Case Presentation

Case 1

A 42-year-old woman with a history of anterior chamber intraocular lens (ACIOL) implantation and a subsequent IOL exchange procedure in her left eye six months ago presented to the clinic, complaining of a color difference between her two eyes (heterochromia). Cosmetic femtosecond laser-assisted intrastromal keratopigmentation (FIK) was performed for the left eye. Pre-operative, 1 month, 1 year, and 3 years post-operative photos are shown in Fig. 1. As it is shown, no pigment migration or color fading is seen after 3 years of FIK.
Fig. 1
Cosmetic femtosecond laser-assisted intrastromal keratopigmentation (FIK) procedure for heterochromia: A Pre-op, B 1month post-op, C 1 year post-op, and D 3 years post-op
Bild vergrößern

Case 2

A 71-year-old man with a history of blunt trauma and aphakia in the left eye was referred to the clinic. He first underwent secondary scleral fixation IOL implantation using the Yamane technique. Six months after the procedure, he experienced bothersome photophobia due to a large iris defect in the inferonasal and supranasal quadrants. Consequently, the left eye underwent cosmetic therapeutic FIK. Pre-operative and 6 months post-operative photos are shown in Fig. 2.
Fig. 2
Cosmetic therapeutic femtosecond laser-assisted intrastromal keratopigmentation (FIK) procedure for iris defect: A Pre-op, B 6 months post-op
Bild vergrößern

Case 3

A 34-year-old woman with a history of iris laser depigmentation for cosmetic purposes, who was dissatisfied with her appearance, was referred to the clinic. She underwent cosmetic FIK in both eyes. Figure 3 shows pre-operative, 6 months, 1 year, 2 years, and 3 years post-operative photos. There is no pigment fading or migration after 3 years, as shown in the post-operative photos.
Fig. 3
Cosmetic femtosecond laser-assisted intrastromal keratopigmentation (FIK) procedure for eye color change: A Pre-op, B 6 months post-op, C 1 year post-op, D 2 years post-op, and E 3 years post-op
Bild vergrößern

Case 4

A 46-year-old man with a history of penetrating trauma to the left eye, which had been primarily repaired, was referred to the clinic due to dissatisfaction with the appearance of his left eye. Slit-lamp examination revealed a dense linear corneal scar with adjacent opacities and extensive peripheral anterior synechia. He underwent superficial keratectomy followed by cosmetic superficial automated keratopigmentation (SAK) in the left eye. Pre-operative and 6 months post-operative photos are shown in Fig. 4.
Fig. 4
Superficial keratectomy and cosmetic superficial automated keratopigmentation (SAK) procedure for corneal scarring: A Pre-op and B 6 months post-op
Bild vergrößern

Case 5

A 48-year-old woman with a history of tuberculosis uveitis in the left eye, which had resulted in vision loss, was referred to the clinic due to concerns about the appearance of her left eye. Slit-lamp examination revealed a vascularized corneal scar with extensive lipid deposition. She underwent superficial keratectomy followed by cosmetic superficial automated keratopigmentation (SAK) in the left eye. Figure 5 shows pre-operative and 6 months post-operative photos.
Fig. 5
Superficial keratectomy and cosmetic superficial automated keratopigmentation (SAK) for vascularized corneal scarring and lipid deposition: A pre-op, B 6 months post-op
Bild vergrößern

Case 6

A 45-year-old woman with a history of traumatic cataract in her right eye, who had previously undergone cataract surgery with in-the-bag IOL implantation, was referred to the clinic. She experienced photophobia and monocular double vision in addition to concerns about her eye's appearance due to an inferior iris defect. Therapeutic cosmetic FIK was performed on the right eye. Pre-operative and 6 months post-operative photos are shown in Fig. 6.
Fig. 6
Therapeutic cosmetic femtosecond laser-assisted intrastromal keratopigmentation (FIK) for iris defect: A pre-op, B 6 months post-op
Bild vergrößern

Case 7

A 52-year-old woman presented to the clinic complaining of photophobia in her right eye and also the color difference between her two eyes. She underwent therapeutic cosmetic FIK in the right eye. Pre-operative, 1 month, 1 year, and 2 years post-operative photos are shown in Fig. 7.
Fig. 7
Therapeutic cosmetic femtosecond laser-assisted intrastromal keratopigmentation (FIK) for heterochromia. A Pre-op, B month post-op, C 1 year post-op, D 2 years post-op
Bild vergrößern

Discussion

Results of the study demonstrates that superficial and intrastromal KTP with micronized mineral pigments (MMPs) are considered safe procedures if the selected technique matches the underlying pathology (based on pre-operative evaluations) and is done by an experienced surgeon.
The cornea can be colored by embedding coloring agents or reducing metallic salts in situ into the corneal stroma. Toxic reactions to the pigment, color fading, color change, and over- or underpigmentation are the main complications that come with these agents [16, 17]. Sirerol et al. evaluated the tolerance and biocompatibility of MMPs in an animal model (leghorn hens) and concluded that a good cosmetic appearance without any negative effects was displayed by central KTP [16]. Another in vitro study by Amesty et al. in an experimental animal model (New Zealand rabbits) reported the same results [17]. The findings indicate that MMPs are suitable for achieving successful KTP. Advantages of using MMPs are less foreign-body reaction in comparison to traditional tattoo inks and a wide range of available colors primarily or by mixing colors [16, 17].
No intra-operative complication occurred during the study. Except for one case, which developed bacterial keratitis, no eye developed serious post-operative complications necessitating aggressive treatment. The most common post-operative symptom was photophobia (28.2%), followed by tearing (23.5%), and pain (8.2%). Most cases with such symptoms were in the SAK group. Salini et al. found that the intrastromal needle puncture technique (ISNT) caused more watering and redness (p > 0.001) than the intrastromal pocket technique (ISPT), which was resolved in 70.4% of patients after 4 weeks [18]. Invading the most anterior parts of the cornea, including the epithelium, Bowman’s layer, and nerves during SAK, may lead to delayed epithelial healing, recurrent epithelial erosions, dry eye, and pain. This may explain the higher occurrence of postoperative symptoms in the SAK group. Moreover, the corneal conditions in the SAK group were mostly the ones where the corneal layers were previously damaged, causing the post-operative symptoms to be more frequent in the SAK group.
Post-operative complications were rare in the present study (9.4% in total) with the most common by 5.8%, which was filamentary keratitis. Post-operative symptoms were photophobia (light sensitivity) in 28.2%, tearing in 23.5%, and pain in 8.2%. Alio et al. reported the first cases of performing intrastromal KTP using MMPs in a case series including seven patients [8] and then studied and reported the outcomes of 234 eyes that received KTP with various techniques and reported the complication rate as 12.82% [15]. The most common complication of their study was light sensitivity (49% of complicated eyes), whereas the least ones were visual field limitation and magnetic resonance imaging (MRI), alterations that occurred in 4% and 2% of complicated eyes, respectively. Other reported complications were color fading, change in color (both 19% of complicated eyes), and neovascularization (7% of complicated eyes). The rate of pigment fading in our study was 20% of all eyes, which occurred, on average, 3.35 months after the initial procedure. Differences in study population regarding the underlying pathologies and differences in number of SAK and FIK procedures between the two studies are the reason for different post-operative complications and symptom rates. Yilmaz et al. studied 42 eyes that had colored corneal tattoos applied with an automated tattoo pen machine for aesthetic reasons but had no visual potential. They reviewed pre- and post-operative (day 1, week 1, months 1, 3, and 12) slit photos of the patients and by utilizing an online Color Code Finder program, they determined red, green, and blue (RGB) and hue, saturation, and lightness (HSL) values of the tattooed areas, like pupil and iris. They stated that the first month was when the majority of the fading happened. The black-colored pupil's L value increased after the first month at a lower rate than the brown- or green-colored iris. Light colors fade more quickly, according to these findings [19]. A case of pigment migration into the optical zone was observed in an FIK patient 5 years after the procedure, with eye rubbing suspected as the primary cause. Therefore, advising patients to avoid rubbing their eyes after KTP procedures would be a reasonable precaution.
The results of the present study seem to confirm previous reports concerning the use of superficial and intrastromal KTP as effective procedures providing good cosmetic outcomes [1, 5, 8, 11, 14, 15]. The observer’s reported cosmetic outcome was excellent or good in 91.8% of all study cases. Cosmetic outcome was excellent or good in 91.4%, 91.5%, and 100% in SAK, FIK, and SAK + FIK groups, respectively, according to the observer’s reported cosmetic outcome 6 months postoperatively. Al-Shymali et al. studied 130 cases and reported excellent or good cosmetic appearance evaluated by the observer in 98.5% of eyes that underwent superficial KTP [14]. Eighty percent of the patients in our study were highly satisfied or satisfied with their cosmetic outcome in general. The rate of patient’s cosmetic satisfaction was 73.9%, 86% and 100% in SAK, FIK, and SAK + FIK groups, respectively. Unsatisfied patients were the cases where pigment fading occurred during the follow-up period. Twelve eyes in the SAK group (26%) and five eyes in FIK group (13.8%) needed to repeat the initial procedure due to color fading. All patients were highly satisfied or satisfied after the second KTP procedure.
We may conclude that after undergoing their first or, at most, their second KTP procedure, 100% of the study participants were highly satisfied or satisfied with their cosmetic result. Alio et al. studied 40 patients who underwent superficial or interlamellar KTP and reported that eight cases needed a second KTP after 1 year of follow-up and 95% of patients’ reported cosmetic satisfaction [11]. Another study of 16 eyes underwent MSK and MIK reported mean patient satisfaction score of 4.18 ± 0.75 points (range, 3–5 points), with a 0–5 points satisfaction grading system [20]. Salini et al. reviewed 463 patients who underwent either intrastromal needle puncture technique (ISNT) or intrastromal pocket technique (ISPT) during 7 years and reported excellent levels of satisfaction in 375 (80.9%) patients and good satisfaction levels in 45 (9.7%) patients; 5.3% of patients in the ISNT group required a repeat of the procedure [18].
The study showed that superficial and intrastromal KTP are effective procedures in treating visual symptoms related to iris abnormalities, a procedure that is called functional or therapeutic KTP. Of 21 patients with visual symptoms due to iris abnormalities, 16 were treated by FIK, three were treated by SAK, and two were treated by SAK + FIK; 100% of patients were highly satisfied or satisfied with their functional outcome. Several studies have demonstrated the effectiveness of KTP in functional improvement of the eyes with iris abnormalities for various causes [1, 2, 57, 21]. Alio et al. reported improvement of visual function-related symptoms by manual intralamellar KTP (MIK), SAK, and FIK (FAK) in 11 eyes with moderate-to-severe visual disabilities due to iris defects [5]. Another study conducted on 19 eyes that had significant visual impairment due to iris defects and underwent FIK (FAK) revealed that all patients experienced an improvement in their prior visual-related symptoms, and 94% of the eyes showed an improvement in their best-corrected Snellen visual acuity [3].
The current study is one of the largest reported retrospective consecutive studies of cosmetic and therapeutic KTP using MMPs by including 85 patients after Alio et al.'s work in 2017 [15], which included 234 patients. Thus, the results of this study confirm the previously reported findings regarding the cosmetic and therapeutic outcomes of KTP using MMPs.
The retrospective nature of the study, non-randomized and non-controlled cohorts, and small sample size are some of its limitations.

Conclusions

In conclusion, according to the results reported in this study, SAK and FIK using micronized mineral pigments are confirmed as safe and efficient therapeutic surgical techniques for managing cosmetic and functional disabilities caused by corneal opacities of a variety of etiologies and iris abnormalities causing functional disabilities.

Acknowledgements

We thank the participants of the study.

Declarations

Conflict of Interest

Seyed Javad Hashemian and Sepehr Roozdar declare that they have no competing interests. Jorge L. Alió is an Editorial Board member of Ophthalmology and Therapy. Jorge L. Alió was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

Ethical Approval

Prior to surgery, a standardized informed consent was acquired, and the cosmetic goal and potential complications were described to the participants both verbally and through a written informative paper. This study adhered to the principles of the Declaration of Helsinki. Ethical board committee approval was obtained from the ethics committee of Iran University Faculty of Medicine for this retrospective investigation. Written consent was obtained from the participants to publish their pre-op and post-op photos.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Download
Titel
Therapeutic Keratopigmentation: Cosmetic and Functional Outcomes
Verfasst von
Seyed Javad Hashemian
Sepehr Roozdar
Jorge L. Alió
Publikationsdatum
03.04.2025
Verlag
Springer Healthcare
Erschienen in
Ophthalmology and Therapy / Ausgabe 5/2025
Print ISSN: 2193-8245
Elektronische ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-025-01131-0

Supplementary Information

Below is the link to the electronic supplementary material.
1.
Zurück zum Zitat Alio JL, et al. Femtosecond-assisted keratopigmentation double tunnel technique in the management of a case of Urrets-Zavalia syndrome. Cornea. 2012;31(9):1071–4.CrossRefPubMed
2.
Zurück zum Zitat Ricardo JRS, Medhi J, Pineda R. Femtosecond laser-assisted keratopigmentation for the management of visual disabilities due to peripheral iridectomies. J Glaucoma. 2015;24(4):e22–4.CrossRefPubMed
3.
Zurück zum Zitat Yin HY, Walter KA. Long-term outcome of femtosecond laser-assisted keratopigmentation: using Intacs channels for precise pigment deposition within the cornea. Cornea. 2021;40(10):1330–5.CrossRefPubMed
4.
Zurück zum Zitat Morales-Wong F, et al. Femtosecond laser applications in corneal surgery. Taiwan J Ophthalmol. 2023;13(3):293–305.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Alio JL, Rodriguez AE, Toffaha BT. Keratopigmentation (corneal tattooing) for the management of visual disabilities of the eye related to iris defects. Br J Ophthalmol. 2011;95(10):1397–401.CrossRefPubMed
6.
Zurück zum Zitat Gupta D, Broadway D. Cost-effective tattooing: the use of sterile ink for corneal tattooing after complicated peripheral iridotomies: an alternative to expensive salts. J Glaucoma. 2010;19(8):566–7.CrossRefPubMed
7.
Zurück zum Zitat Segal L, Choremis J, Mabon M. Intrastromal corneal tattooing for symptomatic iridotomies. Br J Ophthalmol. 2012;96(3):464–5.CrossRefPubMed
8.
Zurück zum Zitat Alió JL, et al. Keratopigmentation to change the apparent color of the human eye: a novel indication for corneal tattooing. Cornea. 2016;35(4):431–7.CrossRefPubMed
9.
Zurück zum Zitat D’Oria F, et al. Cosmetic Keratopigmentation in sighted eyes: medium-and long-term clinical evaluation. Cornea. 2021;40(3):327–33.CrossRefPubMed
10.
Zurück zum Zitat D’Oria F, Abu-Mustafa SK, Alio JL. Cosmetic change of the apparent color of the eye: a review on surgical alternatives, outcomes and complications. Ophthalmol Therapy. 2022;11(2):465–77.CrossRef
11.
Zurück zum Zitat Alio JL, et al. Corneal tattooing (keratopigmentation) with new mineral micronised pigments to restore cosmetic appearance in severely impaired eyes. Br J Ophthalmol. 2010;94(2):245–9.CrossRefPubMed
12.
Zurück zum Zitat Hasani H, et al. Keratopigmentation: a comprehensive review. Eye. 2020;34(6):1039–46.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Mannis MJ, Eghbali K, Schwab IR. Keratopigmentation: a review of corneal tattooing. Cornea. 1999;18(6):633–7.PubMed
14.
Zurück zum Zitat Al-Shymali O, et al. Superficial keratopigmentation: an alternative solution for patients with cosmetically or functionally impaired eyes. Cornea. 2019;38(1):54–61.CrossRefPubMed
15.
Zurück zum Zitat Alio JL, et al. Keratopigmentation with micronised mineral pigments: complications and outcomes in a series of 234 eyes. Br J Ophthalmol. 2018;102(6):742–7.CrossRefPubMed
16.
Zurück zum Zitat Sirerol B, et al. Tolerance and biocompatibility of micronized black pigment for keratopigmentation simulated pupil reconstruction. Cornea. 2011;30(3):344–50.CrossRefPubMed
17.
Zurück zum Zitat Amesty MA, et al. Tolerance of micronized mineral pigments for intrastromal keratopigmentation: a histopathology and immunopathology experimental study. Cornea. 2016;35(9):1199–205.CrossRefPubMed
18.
Zurück zum Zitat Mohan S, et al. Intrastromal keratopigmentation: a boon for unsightly corneal scars. Int Ophthalmol. 2023;43(8):2787–94.CrossRefPubMed
19.
Zurück zum Zitat Yilmaz OF, Oguz H. Aesthetic corneal tattooing/keratopigmentation using tattoo pen machine: choosing suitable method and color. Graefes Arch Clin Exp Ophthalmol. 2023;261(12):3531–40.CrossRefPubMed
20.
Zurück zum Zitat Karslioglu MZ, et al. Keratopigmentation: is it a miracle or an adventure? Beyoglu Eye Journal. 2020;5(1):32.PubMedPubMedCentral
21.
Zurück zum Zitat Burris TE, Holmes-Higgin DK, Silvestrini TA. Lamellar intrastromal corneal tattoo for treating iris defects (artificial iris). Cornea. 1998;17(2):169–73.CrossRefPubMed

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Krebs: Viel Schmerz am Lebensende

Das Gros der Krebspatientinnen und -patienten leidet in der letzten Lebenswoche an Schmerzen, wobei die Belastung bei bestimmten Entitäten besonders hoch ist. Das zeigt eine große Registerdatenanalyse aus Schweden. Wurden Schmerzen strukturiert erfasst, stieg die Chance, diese vollständig zu lindern.      

Regierung will Krebsprävention und Survivorship-Angebote ausbauen

Zur Eröffnung des Deutschen Krebskongresses (DKK) hat die Bundesregierung ihre Krebsagenda vorgestellt. An der Aufweichung der Krankenhausreform gab es deutliche Kritik. 

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Blut-Hirn-Schranke auf Labor-Chip simuliert (Link öffnet in neuem Fenster)

Hirntumoren sind nach wie vor schlecht therapierbar. Eine Ursache ist die Blut-Hirn-Schranke, die viele Therapeutika daran hindert in Hirntumoren einzudringen. Michelle Zimmer, EPO Experimental Pharmacology & Oncology Berlin-Buch, arbeitet an einem Modell, das die Blut-Hirn-Schranke simuliert, um so die Permeabilität von Medikamenten besser untersuchen zu können.

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Drei neue Strategien gegen Pankreaskarzinom – Hoffnung durch KI & Co.?

Die Inzidenz des Pankreaskarzinoms steigt, die Mortalität ist trotz aller Bemühungen gleichgeblieben. Den Erfolg der Behandlung sollen Netzwerkprojekte mit interdisziplinärer Zusammenarbeit bei der Erforschung molekularer Grundlagen und Behandlungsmöglichkeiten und die Verwendung moderner Technologien wie der Künstlichen Intelligenz (KI) ändern. 

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Person hält die Hand eines Krebspatienten im Bett/© Photographee.eu / stock.adobe.com (Symbolbild mit Fotomodell), Eröffnungsveranstaltung zum Deutschen Krebskongress 2026 in Berlin/© Peter-Paul Weiler, Michelle Zimmer/© Renate Babnik / DKG e.V., Pankreaskarzinom in der Photon-Counting-CT/© Wöltjen M M & Kröger J R / all rights reserved Springer Medizin Verlag GmbH